Learn about our comprehensive antibody validation methods to ensure monospecificity.  Antibody Validation>>

VWF Antibodies

The monomeric form of Von Willebrand factor (VWF) has a molecular weight of approximately 220 kDa. This protein is primarily synthesized and released by endothelial cells, which line the blood vessels, and megakaryocytes, which are precursors to platelets. VWF has two main functions in blood clotting: platelet adhesion and stabilization of clotting factor VIII.

Von Willebrand Disease (VWD) is a hereditary bleeding disorder caused by a deficiency or dysfunction of this factor. It can lead to prolonged bleeding after injury or surgery and may involve spontaneous bleeding in severe cases.

Antibodies against VWF are used in research to study the expression, structure, and function of the Von Willebrand factor. In diagnostics, immunological assays, such as enzyme-linked immunosorbent assays (ELISAs), using these antibodies can help assess this factor’s quantity and functionality in patient samples.


von Willebrand factor | von Willebrand antigen 2, von Willebrand antigen II, Coagulation Factor VIII, Factor VIII Related Antigen, F8VWF, von Willebrand Antigen 2, von Willebrand Disease (vWD)

Research Areas

Cardiovascular, Angiogenesis, Endothelial Cell Marker, Infectious Disease, Signal Transduction

Showing all 17 results


Showing all 17 results


We hold Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.